Anemia drug 'does not improve outcomes' in heart failure patients Spire Healthcare Researchers from Sahlgrenska Academy, University of Gothenburg, in Sweden claim that darbepoetin alfa cannot reduce risk of death from heart failure or improve health in patients with anemia. The discovery was made when patients were given either ... |
